申请人:Hoffmann-La Roche Inc.
公开号:US20160264585A1
公开(公告)日:2016-09-15
The present invention relates to compounds of formula (I), wherein A, B, R
1
and R
2
are
as defined herein before useful for the treatment of psychiatric disorders.
本发明涉及式(I)的化合物,其中A,B,R1和R2如前所定义,可用于治疗精神障碍。